Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com
Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Read more

Novartis' expenditure on research and development 2004-2020

Published by Matej Mikulic, Feb 2, 2021
This statistic shows the expenditure on research and development of Swiss-based pharmaceutical company Novartis from 2004 to 2020. Novartis AG is one of the world's largest pharma companies. In 2020, Novartis spent approximately nine billion U.S. dollars on research and development.

Novartis AG's expenditure on research and development from 2004 to 2020 (in billion U.S. dollars)

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account
$39 $59 per month *
in the first 12 months
View for free
33% discount until May 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Additional Information

© Statista 2021

Show source

Show detailed source information?
Register for free
Already a member?
Log in
Source

Show sources information
Show publisher information

Release date

January 2021

Region

Worldwide

Survey time period

2004 to 2020

Supplementary notes

This statistic was assembled from several annual reports.
* With the 2015 Annual Report, values back to 2011 were restated, as a result of a series of transactions during 2015.
** During 2019, eye care division Alcon was spun off and became an own company. Thus, Alcon's expenses are not included.

Open this statistic in...
French
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Novartis"

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Further Content: You might find this interesting as well

Statistics

Topics

NovartisGlobal pharmaceutical industryPharmaceutical industry in the U.S.Pfizer
Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Menu